They should be cared about my health and not take things away from me.
Diabetes 67(Supplement 1):522 Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P et al (2019) Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
These include severe, persistent abdominal pain (which may indicate pancreatitis) and signs of gallbladder disease
Delay doses if vomiting or dehydration occur, and follow your clinicians timing for surgery or sedation
Retatrutide Side Effects (What Trials Show) Clinical research on the retatrutide peptide shows a predictable pattern of side effects similar to GLP-1 and GIP agonists, with additional reactions linked to glucagon activation
HFD-induced GLP-1 resistance was associated with reduced intestinal Glp1r expression and defective GLP-1induced activation of murine enteric neuron circuits linked to CNS GLP-1 action (34)